CYP1A1, cytochrome P450 family 1 subfamily A member 1, 1543
N. diseases: 379; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 1.000 | 5 | 2011 | 2017 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 1.000 | 5 | 2011 | 2017 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.050 | 1.000 | 5 | 2011 | 2017 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 0.750 | 4 | 2010 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.040 | 0.750 | 4 | 2016 | 2018 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 0.750 | 4 | 2010 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 0.750 | 4 | 2010 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2010 | 2017 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2007 | 2007 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2007 | 2007 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.630 | 0.640 | 15 | 74719300 | downstream gene variant | A/G;T | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |